A Scandinavian controlled, randomized, open-label, and multi-centre study evaluating if once-daily tacrolimus or twice-daily cyclosporin, reduces the 3-year incidence of chronic lung allograft dysfunction after lung transplantation
Latest Information Update: 25 Mar 2024
At a glance
- Drugs Tacrolimus (Primary) ; Ciclosporin
- Indications Lung transplant rejection
- Focus Therapeutic Use
- Acronyms ScanCLAD
- 25 Mar 2024 This trial has been Discontinued in Sweden, according to European Clinical Trials Database record
- 01 Feb 2024 This trial has been Discontinued in Finland, according to European Clinical Trials Database record.
- 24 Apr 2023 Status changed from completed to active, no longer recruiting.